Navigation Links
HJF signs distribution agreement for antibody to evaluate prostate cancer
Date:2/18/2011

Rockville, Md. (Feb. 17, 2011)The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) has signed a licensing agreement with Biocare Medical, a biotechnology company based in Concord, Calif., for the exclusive worldwide sales and distribution rights for the immunohistochemistry of an antibody designed to detect tumor prevalence in prostate cancer patients.

The antibody was developed at the Center for Prostate Disease Research (CPDR), a multidisciplinary prostate cancer translational research program that is part of Department of Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Md. HJF supports the center with research management and administrative services.

The mouse monoclonal anti-ERG antibody (CPDR ERG-MAb) can detect the presence of ERG proteins with a high degree of specificity in 50 percent to 70 percent of all patients with prostate cancer. The proteins are linked to cells capable of causing tumor growth. Using the antibody, researchers were able to identify the presence of ERG proteins with an unprecedented 99.9 percent accuracy. Detecting prostate tumor cells in pathologic specimens will aid in diagnostics, prognostics and patient monitoring.

Under a parallel cooperative research and development agreement, Biocare Medical will collaborate with researchers at CPDR, Armed Forces Institute of Pathology and Walter Reed Army Medical Center to further study the anti-ERG antibody and its clinical diagnostic potential.

The CPDR ERG-MAb provided the first insights into the ERG protein expression features in the prostate gland, indicating a strong correlation (97 percent) between the presence of ERG-positive prostatic intraepithelial neoplasia and ERG-positive carcinoma.

Groundbreaking research in the prostate cancer field has established ERG protein activation by recurrent gene fusions as one of the key genomic defects in prostate cancer. The protein is a promising diagnostic marker for identifying prostatic adenocarcinoma and distinguishing it from non-neoplastic prostate and other adenocarcinomas.

The antibody also may be used for detecting ERG protein alterations in other cancers, including endothelial cell derived tumors and acute myelogenous leukemia.


'/>"/>

Contact: JoAnn Sperber
jsperber@hjf.org
301-294-1234
Henry M. Jackson Foundation for the Advancement of Military Medicine
Source:Eurekalert

Related medicine news :

1. Early signs of heart disease in preadolescent children with type 1 diabetes
2. People Look to Eyes for Signs of Life, Study Finds
3. Obese children have signs of heart disease typically seen in middle-aged adults
4. U-M receives NIH, FDA grant to study adaptive clinical trial designs
5. Effective methods for detecting early signs of tremor
6. Friends, family detect early Alzheimers signs better than traditional tests
7. Infants May Display Subtle Autism Signs at 6 Months: Study
8. Mental Exercise May Only Hide Signs of Alzheimers
9. Telltale signs of bioterror
10. Signs of Autism May Show in Early Infancy
11. United Staes Company, First Defense Nasal Screens Signs Multi-Million Dollar Exclusive Distributorship Contract with U.A.E Company.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: